Get the StoQuant digest — free
Free StoQuant digest by email. No account needed.
See today's research picks.
ASRT vs CRDL — Stock Comparison
Compare ASRT and CRDL side-by-side on StoQuant: ASRT Q-Score 48 vs CRDL 50; analyst signal 50 vs 75. Plus alt data signals, insider buying, catalysts, strategic edges, short interest, social sentiment, and macro context.
Side-by-side snapshot
- ASRT — Assertio Holdings, Inc. · Health Care · market cap $152M · Q-Score verdict Hold (48.0, grade C) · analyst signal 50/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: analyst consensus 30/100, technicals 17/100. Full ASRT research.
- CRDL — Cardiol Therapeutics Inc. · Health Care · market cap $135M · Q-Score verdict Unrated (50.0) · analyst signal 75/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: analyst consensus 76/100, technicals 9/100. Full CRDL research.
What you can compare
- Q-Score: StoQuant's composite 0–100 rating based on 140+ financial signals.
- Alt data signals: Google Trends, EDGAR 8-K filings, job postings, and more.
- Insider activity: Cluster scores and recent Form 4 buying.
- Catalysts: Earnings, analyst changes, M&A, clinical trials, and SEC events.
- Strategic edges: Competitive moat and durable advantage analysis.
- Short interest & social sentiment: Short % float, social mention volume, and bullish/bearish breakdown.
- Macro context: Market regime and sector rotation alignment.
Deep dive: ASRT research · CRDL research. Sign in to StoQuant to run live comparisons for any tickers. Sign up free →
Register founding interest — Pro $29/mo or Power $79/mo
Paid plans aren’t for sale yet. Leave your email to lock founding pricing (Pro $29, Power $79); we’ll reach out personally.